Not applicableStudy completedNCT07621835
What this trial is testing
Risk Factors Associated With the Absence of CMV-specific Cellular Immune Response in the Early Post-transplant Period in Low-risk CMV-seropositive Kidney Transplant Recipients
Who this might be right for
CMV Specific Immune ResponseKidney TransplantKidney Transplant Recipient+1 more
Maimónides Biomedical Research Institute of Córdoba 236